Intraductal Papillary Neoplasm of the Bile Duct
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | HER2-positive | Intraductal Papillary Neoplasm of the Bile Duct | Zanidatamab |